Topic: How To Invest

Q: Pat, can I have your opinion on Johnson & Johnson for new buying. Thanks.

Article Excerpt

A: Johnson & Johnson, $149.02, symbol JNJ on New York (Shares outstanding: 2.6 billion; Market cap: $392.6 billion; www.jnj.com), is an American multinational corporation that develops medical devices, pharmaceuticals, and consumer packaged goods. Founded in 1886, and headquartered in New Brunswick, New Jersey, the company is the world’s third-largest pharmaceutical company. Johnson & Johnson operates through three major businesses: Pharmaceutical (54% of revenue) makes anti-infective, antipsychotic, contraceptive, dermatological, and gastrointestinal medicines; Medical Devices (29%) sells a range of orthopedic, surgical, cardiovascular, sterilization, diabetic, and vision-care devices; and Consumer Health (17%) makes over-the-counter products such as Johnson’s baby-care items, Band-Aid bandages, Tylenol and Motrin painkillers, Listerine mouthwash, and Neutrogena skin cream. Sales in the U.S. account for 52% of the company’s total revenue. Over the last five years, Johnson & Johnson’s revenue has increased 17.1%, from $70.1 billion in 2015 to $82.1 billion in 2019. Earnings during that time remained relatively flat, falling 1.9%, from $15.4 billion in 2015 to $15.1 billion in 2019…